Biointron is excited to announce our newly launched CHOK1-Fut8KO expression platform for afucosylated antibodies.
On March 21st, Biointron Biological Shanghai R&D Center welcomed AstraZeneca delegations Mark Cobbold, Margie Li, Hao Huang, and Yingjie Wu for an on-site visit.
You can also contact us on the Scientist and Science Exchange marketplaces.
Our website uses cookies to improve your experience. Read our Privacy Policy to find out more.
